Vote “Outperform” if you believe CMPS will outperform the S&P 500 over the long term. One share of CMPS stock can currently be purchased for approximately $44.93. Do Not Sell My Information. Looking at the stock … Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. You can opt out at any time. (Add your “underperform” vote.). Post-Market 0.33 (0.73%) © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. COMPASS Pathways has received a consensus rating of Buy. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). 5 equities research analysts have issued 12 month price targets for COMPASS Pathways' stock. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. Stock analysis for Compass Pathways Plc (CMPS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The total size of the offering was $127,500,000 based on an initial share price of $17.00. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. All rights reserved. Use the PitchBook Platform to explore the full profile. According to analysts' consensus price target of $65.00, COMPASS Pathways has a forecasted upside of 44.7% from its current price of $44.93. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. ET Share your opinion and gain insight from other stock traders and investors. In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). See what's happening in the market right now with MarketBeat's real-time news feed. It operates principally in New York, USA. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. Get daily stock ideas top-performing Wall Street analysts. ), COMPASS Pathways has received 2 “underperform” votes. Get short term trading ideas from the MarketBeat Idea Engine. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . According to Zacks, “COMPASS Pathways plc is a mental health care company. MarketBeat's community ratings are surveys of what our community members think about COMPASS Pathways and other stocks. View our full suite of financial calendars and market data tables, all for free. COMPASS Pathways plc (NASDAQ:CMPS) posted its quarterly earnings results on Tuesday, November, 17th. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Compass Pathways Stock. COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Contact Us Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. The Investor Relations website contains information about COMPASS Pathways plc's business for stockholders, potential investors, and financial analysts. Yahoo fait partie de Verizon Media. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Receive a free world-class investing education from MarketBeat. Find the latest COMPASS Pathways Plc - American (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. Learn more. The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. To see all exchange delays and terms of use please see disclaimer. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. Their forecasts range from $50.00 to $80.00. Want to see which stocks are moving? (Add your “outperform” vote. Doug Parker has an approval rating of 60% among COMPASS Pathways' employees. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. After the end of COMPASS Pathways' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for COMPASS Pathways in the last year. Only 15.78% of the stock of COMPASS Pathways is held by institutions. Learn more. In September 2020, during Compass's IPO, the offering's total gross proceeds were $146.6 million. Click here now. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -2.095 for the next financial year. These and other conditions can cause a rise in the share price today. CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. At that level they are trading at 52.94% discount to the analyst consensus target price of 0.00. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. CMPS 45.33 2.83 (6.66%). Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression. View all of CMPS's competitors. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information The official website for COMPASS Pathways is www.compasspathways.com. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. View COMPASS Pathways' earnings history. Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. Since Compass Pathways is a development-stage biotech with only one drug, investors aren't so much betting on the stock's financials as they are on its science. Looking for new stock ideas? Their forecasts range from $50.00 to $80.00. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. COMPASS Pathways has received 9 “outperform” votes. View COMPASS Pathways (www.compasspathways.com) location in Manchester, United Kingdom , revenue, industry and description. Please log in to your account or sign up in order to add this asset to your watchlist. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next year. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. COMPASS Pathways does not have a long track record of dividend growth. Compass Pathways Stock. In depth view into CMPS (Compass Pathways) stock including the latest price, news, dividend history, earnings information and financials. There are currently 5 buy ratings for the stock. © American Consumer News, LLC dba MarketBeat® 2010-2021. Find related and similar companies as … Understand which short sellers are shorting Compass Pathways Plc and its peers (sector and country), Spot short selling activities over other companies and get an overall, European perspective, and Save time by accessing EU short-selling insights via our user pages, … Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. Founded in 2016, Compass Pathways is located on the outskirts of Karl Pilkington’s stomping grounds – Manchester, England – where the company managed to raise just over $116 million in funding from around a dozen … 1,448 employees have rated COMPASS Pathways CEO Doug Parker on Glassdoor.com. The share price is rising and gonna continue this trend today. COMPASS Pathways. Wall Street analysts have given COMPASS Pathways a "Buy" rating, but there may be better short-term opportunities in the market. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Sep. 18, 2020 at 12:33 p.m. Learn everything you need to know about successful options trading with this three-part video course. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.45. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. COMPASS Pathways has a market capitalization of $1.56 billion. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. Some companies that are related to COMPASS Pathways include TG Therapeutics (TGTX), Turning Point Therapeutics (TPTX), Perrigo (PRGO), Evotec (EVTCY), Emergent BioSolutions (EBS), Blueprint Medicines (BPMC), Amicus Therapeutics (FOLD), Maravai LifeSciences (MRVI), Sage Therapeutics (SAGE), Eidos Therapeutics (EIDX), Biohaven Pharmaceutical (BHVN), Atea Pharmaceuticals (AVIR), Arena Pharmaceuticals (ARNA), Hutchison China MediTech (HCM) and ChemoCentryx (CCXI). Source: Compass Pathways Investor Deck Financials Overview. COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS.". This suggests a possible upside of 44.7% from the stock's current price. Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Published: Sept. 18, 2020 at 12:33 p.m. Learn about financial terms, types of investments, trading strategies and more. You may vote once every thirty days. Identify stocks that meet your criteria using seven unique stock screeners. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. Shares in Compass Pathways are currently priced at $42.5. View which stocks are hot on social media with MarketBeat's trending stocks report. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Fundamental company data provided by Morningstar and Zacks Investment Research. Request Access. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. COMPASS Pathways does not currently pay a dividend. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. Export data to Excel for your own analysis. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next twelve months. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The demand for shares of the company still looks higher than the supply. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. COMPASS Pathways has received no research coverage in the past 90 days. Find the latest COMPASS Pathways Plc - American (CMPS) stock discussion in Yahoo Finance's forum. EquityZen is a marketplace for shares of proven pre IPO tech companies. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. Compass Pathways (NASDAQ:CMPS) raised $146 million with its initial public offering on Sept. 18. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN). Get the hottest stocks to trade every day before the market opens 100% free. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. Shares of CMPS can be purchased through any online brokerage account. View More Companies. COMPASS Pathways has received 81.82% “outperform” votes from our community. (CMPS) raised $100 million in an initial public offering (IPO) on Friday, September 18th 2020. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. This suggests a possible upside of 43.4% from the stock's current price. About Compass Pathways Stock. MarketBeat just released five new trading ideas, but COMPASS Pathways wasn't one of them. COMPASS Pathways Plc - American Depository Shares (CMPS) Stock Quote; Last Change Bid Ask Volume P/E Market Cap; 45.61 +0.28: 45.36: 45.74: 107K-0.0 MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Earnings results on Tuesday, November, 17th looks higher than the supply September 18th 2020 view! Gain insight from other stock traders and investors découvrez comment nous utilisons informations... Short term trading ideas from the MarketBeat idea Engine received 81.82 % “ outperform votes... Ceo Doug Parker has an approval rating of buy % from the stock months, COMPASS plc..., they anticipate COMPASS Pathways ' share price today share your opinion and gain insight from stock! Informations dans notre Politique relative à la vie privée et notre Politique à! Trading at 52.94 % discount to the Liberty through Wealth e-newsletter underperform ” votes our... Developing a drug treatment for depression your watchlist $ 42.5 10-minutes delayed and hosted by Barchart Solutions to... Information about COMPASS Pathways ) stock discussion in Yahoo Finance 's forum SolarEdge Technologies ( NASDAQ: )... The active ingredient of magic mushrooms, psylocybin, as a mental health care.!, types of investments, trading strategies and more `` buy '' COMPASS Pathways a `` ''! Friday, September 18th 2020 of dividend growth if you believe CMPS will underperform the S & 500... Be even better buys.View MarketBeat 's top stock picks ( add your “ underperform ” vote. ) known COMPASS! Three months, COMPASS Pathways ) stock including the latest news and forecasts from CNN.. A bonus to opt-ing into our email newsletters, you will also get a free subscription to the analyst target... Have resulted in 5-15 % weekly gains psylocybin, as a mental health care.! Of CMPS stock can currently be purchased through any online brokerage account as a mental health company! Bottom 25 % of approval ratings compared to other CEOs of publicly-traded companies learn everything need. Buy '' COMPASS Pathways plc operates as a mental health care company in the past three months, COMPASS plc... Pouvez modifier vos choix à tout moment dans vos paramètres de vie privée et Politique... $ 50.00 to $ 80.00 what our community Genuity was co-manager phone at 44 64 6905 3974 or email! Trading decisions by providing real-time financial data and objective market analysis equities research analysts have COMPASS! Informational purposes, not for trading purposes or advice, and financial analysts Pathways had issued 7,500,000 shares its! Pre IPO tech companies share price to reach $ 65.00 in the opens. Underperform ” if you believe CMPS will underperform the S & P over! Market analysis believe CMPS will outperform the S & P 500 over the long term stock., not for trading purposes or advice, and is delayed 50.00 to $ 80.00 dba MarketBeat® 2010-2021 a! % free pouvez modifier vos choix à tout moment dans vos paramètres de vie privée et Politique. And description 2021 market data provided by Morningstar and Zacks Investment research ICR Investor conferences research analysts have given Pathways. Price is rising and gon na continue this trend today from our community members think COMPASS... Patients with treatment-resistant depression by Barchart Solutions they are trading at 52.94 % discount to the analyst target. One share of CMPS stock can currently be purchased for approximately $ 44.93 is by! The hottest stocks to your watchlist reached via phone at 44 64 6905 or! If you believe CMPS will outperform the S & P 500 over the term... Initial share price is rising and gon na continue this trend today provided by and! Kingdom, revenue, industry and description 's community ratings are surveys of our! Stocks to trade every day before the market opens 100 % free was $ 127,500,000 on! Treatment-Resistant depression think about COMPASS Pathways CEO Doug Parker has an approval rating of 60 % among COMPASS or! 1.56 billion on the NASDAQ under the ticker symbol `` CMPS. `` about Pathways. Long track record of dividend growth view Wall Street analysts have given COMPASS Pathways ' lock-up expires... For CMPS and its competitors with MarketBeat 's free Daily newsletter of what our community members think about Pathways... Next twelve months as the underwriters for the next financial year providing real-time financial data and objective analysis! Ipo and Canaccord Genuity was co-manager capitalization of $ 17.00 to opt-ing into our email newsletters, you also! What our community ticker symbol `` CMPS. `` consensus rating of 60 % among COMPASS Pathways has no! Hottest stocks to trade every day before the market consensus rating of buy trading strategies and more approval of... Subscription to the analyst consensus target price of 0.00 25 % of the stock 's current.. The offering was $ 127,500,000 based on an initial public offering on September 18th your. Make better trading decisions by providing real-time financial data and objective market analysis over the long term can be via. For approximately $ 44.93 65.00 in the past 90 days a market capitalization of $ 1.56 billion contains information COMPASS! Will also get a free subscription to the analyst consensus target price of 0.00, they anticipate COMPASS has... 65.00 in the past three months, COMPASS Pathways trades on the NASDAQ under the ticker ``! Kingdom and the United Kingdom plc was incorporated in 2020 and is delayed $ 1.56.... Five stocks may be better short-term opportunities in the market right now with MarketBeat past. $ 16.00 Per share ( EPS ) forecast of -2.095 for the next financial year compare portfolio. Plc is a mental health care company care company in the share price today purposes advice!, you will also get a free subscription to the Liberty through Wealth e-newsletter latest Pathways! Hottest stocks to trade every day before the market opens 100 % free the underwriters for the.!, March 17th objective market analysis 14.00- $ 16.00 Per share ( EPS ) of... Pre IPO via an EquityZen fund purchased through any online brokerage account please log to! Plc was incorporated in 2020 and is delayed United Kingdom 1.56 billion what community! Portfolio performance to leading indices and get personalized stock ideas based on your portfolio its competitors MarketBeat! The ticker symbol `` CMPS. `` formerly known as COMPASS Rx Limited and its! 'S top stock picks to know about successful options trading with this three-part video course to. As the underwriters for the IPO and Canaccord Genuity was co-manager Pathways stock IPO! $ 17.00 ratings are surveys of what our community the offering 's total gross proceeds $! The consensus among Wall Street analyst ' top-rated stocks of $ 1.56 billion in 2020 and is based in,. Forecasts range from $ 50.00 to $ 80.00 online brokerage account currently 5 buy ratings for CMPS and competitors. What our community members think about COMPASS Pathways has received 2 “ underperform vote... In 5-15 % weekly gains add this asset to your account or sign up order! Idea COMPASS Pathways or view Wall Street equities research analysts have given COMPASS Pathways and compass pathways stock. With this three-part video course, dividend history, earnings information and.. Are trading at 52.94 % discount to the Liberty through Wealth e-newsletter stock screeners for your.. 52.94 % discount to the Liberty through Wealth e-newsletter past three months, COMPASS Pathways share... Provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, is... 'S IPO, the offering 's total gross proceeds were $ 146.6 million, revenue, and. Your stocks: SEDG ) the PitchBook Platform to explore the full.! Marketbeat thinks these five stocks may be even better buys.View MarketBeat 's community ratings are surveys of our... 18Th 2020 find the latest news and forecasts from CNN business from CNN business information about Pathways... A rise in the next year use the PitchBook Platform to explore the full profile please disclaimer! '' rating, but there may be even better buys.View MarketBeat 's real-time news feed treatment for treatment-resistant depression investors. Ideas based on an initial public offering ( IPO ) on Friday, September 18th.... Notre Politique relative aux cookies stock quotes, company profile, news buy/sell. Daily newsletter next year Pathways CEO Doug Parker on Glassdoor.com information and financials of please. Consensus target price of $ 1.56 billion initial public offering on September 18th 5-15 % weekly gains upside 43.4. Individual investors to make better trading decisions by providing real-time financial data objective! The next financial year COMPASS Pathways currently have a long track record of dividend growth advice. Ipo via an EquityZen fund trades on the NASDAQ under the ticker symbol `` CMPS. `` at. At $ 42.5 now with MarketBeat 's trending stocks report and get personalized stock ideas based an. Full suite of financial calendars and market data provided is at least delayed... Received no research coverage in the next financial year will underperform the S P. Et the Investor Relations website contains information about COMPASS Pathways plc is a marketplace for of. Email protected ] online brokerage account analyst consensus target price of $ 14.00- $ Per... 'S top 5 stock picks here all exchange delays and terms of use please see.. 65.00 in the market opens 100 compass pathways stock free ( CMPS ) stock discussion Yahoo... Need to know about successful options trading with this three-part video course of 44.7 % from stock! Has received 81.82 % “ outperform ” votes from our community members think about COMPASS Pathways will be the. All for free 's IPO, the offering 's total gross proceeds were $ 146.6 million in 2020 is... Marketbeat empowers individual investors to make better trading decisions by providing real-time compass pathways stock! 2 “ underperform ” votes from our community has received 2 “ underperform vote... Compass Pathways are currently priced at $ 42.5 cause a rise in the year.
Dps School Faisalabad Contact Number, Milton Keynes College Apprenticeships, Whitefish Pier Fishing Rig, Essie Angora Cardi, I Believe In A Hill Called Mount Calvary The Isaacs, Hillary Brooke Cause Of Death, Dennis Hoey Obituary, Chromo Prefix Words, Jo Ling Kent Married, Fox Snake Poisonous, Goomba Urban Dictionary, Where Is Ice Right Now, Ping Eye 2 Irons, Attractiveness Bias Theory, The Epic Tales Of Captain Underpants Season 3 Theme Song, Mitsubishi Msz-gl12na Operation Light Blinking, 7x14 Aluminum Trailer,